These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15448188

  • 21. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD.
    Eur J Pharmacol; 1999 Feb 12; 367(1):139-42. PubMed ID: 10082277
    [Abstract] [Full Text] [Related]

  • 22. N-n-Propyl-substituted 3-(dimethylphenyl)piperidines display novel discriminative properties between dopamine receptor subtypes: synthesis and receptor binding studies.
    Cervetto L, Demontis GC, Giannaccini G, Longoni B, Macchia B, Macchia M, Martinelli A, Orlandini E.
    J Med Chem; 1998 Dec 03; 41(25):4933-8. PubMed ID: 9836610
    [Abstract] [Full Text] [Related]

  • 23. The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.
    Schetz JA, Sibley DR.
    J Pharmacol Exp Ther; 2001 Feb 03; 296(2):359-63. PubMed ID: 11160618
    [Abstract] [Full Text] [Related]

  • 24. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
    Lan H, Durand CJ, Teeter MM, Neve KA.
    Mol Pharmacol; 2006 Jan 03; 69(1):185-94. PubMed ID: 16236817
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates.
    Löber S, Hübner H, Tschammer N, Gmeiner P.
    Trends Pharmacol Sci; 2011 Mar 03; 32(3):148-57. PubMed ID: 21232805
    [Abstract] [Full Text] [Related]

  • 26. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallager DW.
    J Pharmacol Exp Ther; 1997 Aug 03; 282(2):1011-9. PubMed ID: 9262370
    [Abstract] [Full Text] [Related]

  • 27. RBI-257: a highly potent dopamine D4 receptor-selective ligand.
    Kula NS, Baldessarini RJ, Kebabian JW, Bakthavachalam V, Xu L.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):333-6. PubMed ID: 9274997
    [Abstract] [Full Text] [Related]

  • 28. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 29. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor.
    Rowley M, Collins I, Broughton HB, Davey WB, Baker R, Emms F, Marwood R, Patel S, Patel S, Ragan CI, Freedman SB, Ball R, Leeson PD.
    J Med Chem; 1997 Jul 18; 40(15):2374-85. PubMed ID: 9240352
    [Abstract] [Full Text] [Related]

  • 30. 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.
    Hodgetts KJ, Kieltyka A, Brodbeck R, Tran JN, Wasley JW, Thurkauf A.
    Bioorg Med Chem; 2001 Dec 18; 9(12):3207-13. PubMed ID: 11711296
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand.
    Matulenko MA, Surber B, Fan L, Kolasa T, Nakane M, Terranova MA, Uchic ME, Miller LN, Chang R, Donnelly-Roberts DL, Namovic MT, Moreland RB, Brioni JD, Stewart AO.
    Bioorg Med Chem Lett; 2004 Oct 18; 14(20):5095-8. PubMed ID: 15380206
    [Abstract] [Full Text] [Related]

  • 32. A theoretical study to investigate D2DAR/D4DAR selectivity: receptor modeling and molecular docking of dopaminergic ligands.
    Ortore G, Tuccinardi T, Bertini S, Martinelli A.
    J Med Chem; 2006 Feb 23; 49(4):1397-407. PubMed ID: 16480275
    [Abstract] [Full Text] [Related]

  • 33. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1999 Oct 23; 128(3):613-20. PubMed ID: 10516640
    [Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents.
    Leopoldo M, Selivanova SV, Müller A, Lacivita E, Schetz JA, Ametamey SM.
    Chem Biodivers; 2014 Sep 23; 11(9):1298-308. PubMed ID: 25238073
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP, Stevenson DA, Zhuang ZP, Vessotskie JM, Chumpradit S, Sun XM, Kung HF.
    Life Sci; 1997 Sep 23; 60(2):91-100. PubMed ID: 9000114
    [Abstract] [Full Text] [Related]

  • 36. 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channels.
    Carling RW, Moore KW, Moyes CR, Jones EA, Bonner K, Emms F, Marwood R, Patel S, Patel S, Fletcher AE, Beer M, Sohal B, Pike A, Leeson PD.
    J Med Chem; 1999 Jul 15; 42(14):2706-15. PubMed ID: 10411491
    [Abstract] [Full Text] [Related]

  • 37. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 38. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P, Corbett R, Van Tol HH.
    Neuropsychopharmacology; 1997 Feb 15; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [Abstract] [Full Text] [Related]

  • 39. Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents.
    Unangst PC, Capiris T, Connor DT, Heffner TG, MacKenzie RG, Miller SR, Pugsley TA, Wise LD.
    J Med Chem; 1997 Aug 15; 40(17):2688-93. PubMed ID: 9276014
    [Abstract] [Full Text] [Related]

  • 40. PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats.
    Melis MR, Succu S, Mascia MS, Argiolas A.
    Neurosci Lett; 2005 Apr 29; 379(1):59-62. PubMed ID: 15814200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.